Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Pfizer

Roivant, Pfizer Unveil Latest Spinout Focused On Autoimmune Diseases

Roivant Sciences Ltd (NASDAQ:ROIV) and Pfizer Inc (NYSE:PFE) unveiled Priovant Therapeutics, dedicated to developing and commercializing novel therapies for autoimmune diseases. Priovant was established in September 2021 through a transaction between Roivant and Pfizer. Pfizer licensed oral and topical brepocitinib's global development rights and US and Japan commercial rights to Priovant. Pfizer holds a 25%…

Benzinga

US grapples with whether to modify COVID vaccine for fall

U.S. health authorities are facing a critical decision: whether to offer new COVID-19 booster shots this fall that are modified to better match the latest changes of the shape-shifting coronavirus

The Independent UK

US Covid-19 vaccine rollout for under-fives must overcome hesitancy

For many parents the availability of vaccination to the youngest age group is not before time but others plan to ‘wait and see’

The Guardian - US

From analysis to the latest developments in health,
read the most diverse news in one place.

Pfizer’s omicron booster improves immune response, company says

Pfizer’s two omicron-focused booster vaccines massively improve a person’s immune response against the COVID variant, the company said Saturday.

Tribune News Service

Pfizer says its tweaked COVID-19 shots boost protection against the omicron variant

Pfizer said that tweaking its vaccine to better target the omicron variant is safe and works — just days before regulators debate whether to offer Americans updated booster shots this fall.

WEKU

Pfizer says tweaked COVID-19 shots boost omicron protection

Pfizer says tweaking its COVID-19 vaccine to better target the omicron variant is safe and boosts protection

The Independent UK

Misinformation will be rampant when it comes to COVID-19 shots for young children – here's what you can do to counter it

When the Centers for Disease Control and Prevention endorsed both the Pfizer-BioNTech and Moderna COVID-19 vaccines for all children ages 6 months to 5 years on June 18, 2022, it opened the door for nearly 20 million children to get vaccinated.

The Conversation

Read news from The Economist, FT, and more,
with one subscription

Experts endorse Moderna COVID-19 shots for kids ages 6 to 17

An expert panel backed a second COVID-19 vaccine option for kids ages 6 to 17

The Independent UK

Research behind COVID vaccines reaps close to $1 billion in royalties for Penn

PHILADELPHIA — The University of Pennsylvania has reaped extraordinary financial gain from COVID-19 vaccines — approaching $1 billion since the beginning of last year — thanks to patents on a process Penn researchers developed more than 15 years ago.

The Philadelphia Inquirer

Editorial: Now let’s get Florida’s children vaccinated against COVID-19

America’s fight against COVID-19 reached another milestone Tuesday as the nation’s youngest children became eligible for the vaccine. This was a long-awaited moment that should bring relief to millions of American families. Now parents need to do their part by taking this opportunity to protect their children, their households and…

Tribune News Service

What Are Whales Doing With Pfizer

Someone with a lot of money to spend has taken a bullish stance on Pfizer (NYSE:PFE). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Pfizer Strikes Deal With French Vaccine Maker -- Buy Or Sell?

Pharmaceutical company Pfizer (PFE) reported impressive first-quarter financials and is well-positioned to benefit from the equity subscription agreement with French vaccine maker Valneva. However, given the growing economic uncertainty, would it be worth adding the stock to your portfolio? Read more to find out.

StockNews.com

2 million California kids are now eligible for COVID vaccine. How many will get it?

LOS ANGELES — Jonah Stein exited the vaccination clinic in his father’s arms Tuesday afternoon, proud to show off his Band-Aid.

Los Angeles Times

The Daily Biotech Pulse: Precision BioSciences Inks Gene Editing Pact, Athira Pharma's Alzheimer's Candidate Fails, Enanta Sues Pfizer Over COVID-19 Antiviral

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

WEKU

COVID vaccines are finally here for young kids. But the logistics aren't easy

NPR talks to Claire Hannan, who has helped navigate vaccine rollouts in all 50 states, about some of the challenges involved in quickly getting shots out to millions of young kids.

Reuters

COVID-19 vaccine scheme for world's poorest pushes for delivery slowdown

Leaders of the global scheme aiming to get COVID-19 vaccines to the world's poorest are pushing manufacturers including Pfizer and Moderna to cut or slow deliveries of about half a billion shots so doses are not wasted.

Salon

Does Paxlovid work against COVID?

Experts explain how the drug works, where it came from, and what kinds of side effects to expect

Benzinga

Why Shares Of Valneva SE Are Soaring Today

Valneva SE (NASDAQ: VALN) shares are trading higher after the company and Pfizer announced they have entered into an Equity Subscription Agreement and have updated the terms of their Collaboration and License Agreement for Lyme disease vaccine candidate VLA15.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

The Daily Biotech Pulse: Thumbs Down For Acadia's Pimavanserin, Pfizer Buys Stake In Valneva, AstraZeneca - Ionis Eplontersen Aces Rare Disease Trial

Here's a roundup of top developments in the biotech space over the last 24 hours:

Tribune News Service

Editorial: On kids’ vaccines, DeSantis is wrong, but never in doubt

The quip “often wrong, never in doubt” fits Gov. Ron DeSantis like a glove. He takes it to extremes by doubling down, at the expense of our children, on his cultivated political appeal to the anti-vaxxer element of right-wing America.

The Independent UK

Shots for tots: COVID vaccinations start for little US kids

The nation’s youngest children are getting their chance at vaccines for COVID-19

Chicago Sun-Times

Chicago gears up to vaccinate kids under 5 against COVID-19 following federal authorization

From how to prepare your kids to where to get vaccinated, the Sun-Times answers parents’ questions.

Tribune News Service

What you need to know about COVID vaccines for kids under 5

COVID-19 vaccines for children under 5 years old were authorized by the U.S. Food and Drug Administration on Friday and by the Centers for Disease Control and Prevention on Saturday, a welcome relief to parents of the last age group to become eligible for shots.

Boston Herald

Mass. governor's administration approves COVID vaccines for young kids after CDC OK

BOSTON — Parent’s of very young children received some good news from the Baker administration Sunday, when the state announced COVID-19 vaccines would become available Tuesday.

Tribune News Service

Youngest kids in US cleared for Moderna, Pfizer COVID vaccines

U.S. health officials approved COVID-19 vaccines for infants and toddlers, the last remaining age group that hasn’t been eligible for inoculation.

1 … 46 47 48 49

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Centers for Disease Control and Prevention

University of Pennsylvania

121 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.